InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Wengel Kathryn E, Directeur Exécutif. Director active across 2 companies, notably Johnson & Johnson. In total, 5 disclosures have been recorded. The latest transaction was filed on 10 June 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations5 total
€3m40,000 shares@ €68.31020.0005% mcap100.0% of flow
Common Stock
SEC:0001225208-22-008089:0·
603 shares
Common Stock
SEC:0001127602-22-010476:0·
010,386 shares0
Common Stock
SEC:0001225208-22-002374·
010,386 shares0
Common Stock
SEC:0001225208-22-002374:0·
01,896 shares0
Common Stock
SEC:0001225208-22-002217:0·
5 of 5 declarations
About Wengel Kathryn E
Kathryn E. Wengel is Executive Vice President and Chief GSC Officer at JOHNSON & JOHNSON and LABORATORY CORP OF AMERICA HOLDINGS. She oversees supply chain operations and cost management strategy. Her role is essential in ensuring efficiency and innovation in the operational processes of the companies.
